Consolidated Statements of Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net product revenue	$ 169,117	$ 27,963	$ 0
Cost of products sold	15,277	846	0
Gross profit	153,840	27,117	0
Operating expenses:
Research and development expenses	15,196	13,261	20,700
Selling, general and administrative expenses	181,043	151,705	74,516
Restructuring expense	0	0	3,345
Total operating expenses	196,239	164,966	98,561
Operating loss	(42,399)	(137,849)	(98,561)
Investment and other income (expense), net	4,150	87	(536)
Interest expense	(10,830)	(9,886)	(12,342)
Loss on extinguishment of debt	0	(13,129)	0
Loss before income taxes	(49,079)	(160,777)	(111,439)
Income tax (benefit) provision	(247)	(501)	26,025
Net loss	$ (48,832)	$ (160,276)	$ (137,464)
Net loss per share - basic (in dollars per share)	$ (0.51)	$ (2.00)	$ (2.29)
Net loss per share - diluted (in dollars per share)	$ (0.51)	$ (2.00)	$ (2.29)
Weighted average number of shares outstanding - basic (in shares)	95,141	80,174	60,094
Weighted average number of shares outstanding - diluted (in shares)	95,141	80,174	60,094

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.